Market Overview

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

76.23 -1.52 (-1.95%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/23/19UBSInitiates Coverage OnNeutral0.0
12/18/18GuggenheimInitiates Coverage OnBuy105.0
11/28/18Leerink SwannInitiates Coverage OnMarket Perform63.0
10/16/18BMO CapitalMaintainsOutperform124.0
10/01/18Cantor FitzgeraldInitiates Coverage OnOverweight135.0
9/28/18Morgan StanleyMaintainsEqual-Weight87.0
9/13/18Stifel NicolausMaintainsBuy117.0
8/13/18Morgan StanleyMaintainsEqual-Weight93.0
8/13/18B. Riley FBRMaintainsBuy230.0
8/13/18BMO CapitalMaintainsOutperform125.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter